Arrhythmias arise from a complex interaction between structural changes in the myocardium and changes in cellular electrophysiology. Electrophysiological balance requires precise control of sarcolemmal ion channels and exchangers, many of which are regulated by phospholipid, phosphatidylinositol(4,5)bisphosphate. Phosphatidylinositol(4,5)bisphosphate is the immediate precursor of inositol(1,4,5)trisphosphate, a regulator of intracellular Ca 2þ signalling and, therefore, a potential contributor to arrhythmogenesis by altering Ca 2þ homeostasis. The aim of the present review is to outline current evidence that this signalling pathway can be a player in the initiation or maintenance of arrhythmias.
Cardiac arrhythmias arise secondary to a complex interplay between the electrophysiologic properties of cardiac myocytes and structural substrate providing an obstacle to impulse propagation. Although there have been significant advances in our understanding of the mechanisms of cardiac rhythm disturbance, atrial and ventricular arrhythmias still contribute significantly to morbidity and mortality. Sudden cardiac death due to ventricular fibrillation affects 1 in 1000 people and accounts for 10-20% of all deaths in western society. 1 Atrial fibrillation is the most common arrhythmia presenting at cardiology departments world wide, and the incidence is increasing with the aging of the population. 2 A better understanding of the cellular mechanisms will guide future directions and provide new therapeutic options. The phosphoinositides are emerging as potential arrhythmogenic factors, with both membrane phospholipids and soluble signalling molecules potentially involved.
Phosphoinositide signalling, a brief overview
The inositol phospholipids form the structural basis for a complex interplay of signalling responses initiated, most commonly, by receptor activation and resulting in changes in Ca 2þ , protein kinase cascades, and ion channel/exchanger activity. Phosphatidylinositol (PI) itself is a minor phospholipid constituent of all eukaryote plasma membranes. PI is unusual in that it is phosphorylated, most commonly first on the 4-and then on the 5-position to generate PI(4,5)bisphosphate (PIP 2 ), the central player in inositide signalling 3, 4 ( Figure 1 ). Phosphoinositide-derived second messengers regulate responses ranging from immediate changes in vascular tone and hormone secretion to more prolonged responses such as cell growth and differentiation that require transcriptional changes. This wide range of downstream responses is made possible, in part, by the multiple signalling molecules generated from phosphoinositides. [5] [6] [7] [8] [9] Stimulation of appropriate cell surface receptors leads to activation of PI-specific phospholipase C (PLC) enzymes that hydrolyse PIP 2 to generate the hydrophilic acidic end-group inositol (1, 4, 5) trisphosphate (Ins(1,4,5)P 3 ) and the neutral lipid sn-1,2-diacylglycerol (DAG) 5 ( Figure 1 ). In cardiomyocytes, this response is most commonly associated with seven transmembrane receptors that bind a 1 -adrenergic agonists, endothelin, purine nucleotides, or angiotensin, coupled to the Gq family of heterotrimeric G proteins that activate PLCb isoforms. 10, 11 In addition, receptor tyrosine kinases can activate PLCg subtypes in response to growth factors. 12 Ins(1,4,5)P 3 is well established as a regulator of intracellular Ca 2þ by binding its own receptors (IP 3 -R), intracellular Ca 2þ release channels situated on Ca 2þ stores in the endoplasmic reticulum, sarcoplasmic reticulum (SR), or nuclear envelope. 13 DAG remains within the membrane phase and is a co-activator of conventional protein kinase C subtypes.
14 Recent evidence also shows that DAG can activate some of the canonical transient receptor potential (TrpC) channels, independently of PKC. 15 In addition to these PLC-generated products, PIP 2 is also the precursor of PIP 3 following 3 0 -phosphorylation by PI 3-kinases 16 ( Figure 1 ). In addition to PLC cleavage and 3 0 -phosphorylation, PIP 2 can also be hydrolysed by phospholipase D enzymes, generating phosphatidic acid, 17 itself an activator of critical signalling intermediates. 18, 19 Furthermore, PIP 2 , itself, localizes many central signalling proteins to the plasma membrane, 20, 21 and is a regulator of critical ion channels/exchangers (see below).
Any or all of these metabolites have the capacity to influence cardiomyocyte electrical activity and thus could contribute to arrhythmogenesis. However, a specific contribution to arrhythmogenesis has been suggested only for Ins(1,4,5)P 3 and PIP 2 , and therefore these two molecules will be considered here. Figure 2 in relation to RyR and ion channels and exchangers.
Arrhythmic activity associated with
IP 3 -R are expressed at very low level in cardiomyocytes, 1/50 to 1/100 of the RyR that mediate beat-to-beat changes in Ca 2þ to sustain rhythm. 24, 25 Furthermore, most studies report that these are concentrated at the nuclear envelope, seemingly distant from the site of generation of Ins(1,4,5)P 3 at the sarcolemma 26, 27 and from the RyR on the SR. It is difficult to envisage how nuclear receptors could contribute to RyR-initiated transients or perturb sarcolemmal ion channels/exchangers. Addition of Ins(1,4,5)P 3 causes localized Ca 2þ puffs in the perinuclear region, but these are small, unlikely to empty Ca 2þ stores and unlikely to influence RyR function. Despite this, there have been reports of Ins(1,4,5)P 3 -mediated enhanced Ca 2þ signalling, inotropy, and arrhythmias in ventricular myocytes from some species, although not in others. [28] [29] [30] It is currently not clear whether this reflects an undetectable number of strategically placed IP 3 -R present on SR Ca stores in ventricular myocytes of responding species. IP 3 -R expression is higher in atrial than in ventricular myocytes and the existence of sub-sarcolemmal IP 3 -R has been reported, 25, 31 leading to the suggestion that atrial rather than ventricular arrhythmias might be associated with perturbations in Ins(1,4,5)P 3 signalling. 31 In support of this hypothesis, deletion of the IP 3 -R(2) gene in murine atrial myocytes prevented endothelin-1-induced Ca 2þ transients, which are known to be arrhythmogenic. 32 IP 3 -R expression in conducting myocytes is higher than in the working myocytes and the IP 3 -R subtype is different; type 2 in working myocytes and type 1 in conducting tissue. 25, 33 Furthermore, some IP 3 -R(1) are localized close to the sarcolemma in conducting myocytes. 34 Thus, it is possible that ventricular arrhythmias apparently associated with Ins(1,4,5)P 3 derive primarily from the conducting tissue. [35] [36] [37] This is difficult to prove directly, but the generation of mice with knock-outs of the IP 3 -R subtypes in heart will provide definitive evidence for or against this hypothesis.
3. Arrhythmic activity associated with PIP 2 
General considerations
The limited data available suggest that PIP 2 is a tightly regulated molecule. Studies in our laboratory and others have found very similar amounts of PIP 2 in mouse, rat, and human heart tissue, 100-150 pmol/mg protein, and values in atria and ventricle are similar. [38] [39] [40] Attempts to increase overall PIP 2 content by overexpressing PIP 5-kinases is generally met with accommodating changes in other enzymes, resulting in overall unchanged PIP 2 . 41 Recent evidence suggests a scenario where there are functionally different pools of PIP 2 . Different PIP 5-kinase subtypes appear to generate functionally different pools of PIP 2 . 42 Specifically, PIP5K1a associates with the monomeric G protein Rac, PIP5K1b is critical for endocytosis, and PIP5K1g targets to focal adhesion sites. 43 There is now ample evidence that acute localized depletion of PIP 2 can occur close to receptor-activated PLC 44 and this can be sufficient to inactivate adjacent K IR or Kv channels. However, there are also instances where PLC activation is associated with increased PIP 2 , presumably reflecting direct or indirect activation of PI and PIP kinases following activation of PLC-coupled receptors. 38, 39, 45 Ion channels and exchangers regulated by PIP 2 are listed in Table 1 .
Inward rectifying K 1 channels
There are three major inwardly rectifying K þ channels (K IR ) in the heart that are critical regulators of cardiac rhythm, K IR 2, K IR 3, and K IR 6, and all of them require PIP 2 for activity. K IR 2 family members are responsible for the I KI current that maintains resting membrane potential in atrial and ventricular myocytes. K IR 3 channels in atrial and pacemaker myocytes are muscarinic potassium channels (K ACh ) that are targets of parasympathetic control in the heart. The Kir3 current is involved in atrial tachycardia-induced electric remodelling and plays a significant role in the pathophysiology of atrial fibrillation (AF). 46 The K IR 6 family comprise the K ATP channels that are regulated in an inhibitory manner by intracellular ATP. 47 Under normal metabolic conditions, K ATP channels are not significantly open and thus do not contribute to action potential repolarization and excitation-contraction coupling. However, when Phosphoinositides and arrhythmias myocytes are exposed to metabolic stress, K ATP channels open, causing action potential shortening and contractile dysfunction. K IR channels are tetramers, with each subunit comprising two transmembrane segments and a pore loop, that together form a transmembrane pore. The four cytoplasmic loops from each subunit in the tetrameric channel form a girdle around the central cytoplasmic pore. 48 This structure forms a flexible diffusion barrier between the cytoplasm and the transmembrane pore 48, 49 ( Figure 3) . Opening of K IR channels requires PIP 2 binding to basic and polar amino acids in cytoplasmic domains, whereas depletion of PIP 2 acts to close the channel. 50 Mutations in K IR 2.1 channel proteins resulting in lowered PIP 2 binding affinity are a cause of Anderson's syndrome, a condition associated with ventricular arrhythmias, 51 demonstrating the importance of PIP 2 in cardiomyocyte electrophysiology and arrhythmogenesis.
K IR 3 channels (K Ach ) in atria and sino-atrial node belong to the G protein regulated inward rectifying K þ channel family (GIRK), 49, 52 which are regulated via activation of the heterotrimeric G protein, Gi, causing release of Gbg subunits. Regulation of K ACh channel activity is crucially dependent on PIP 2 . 53 Blockade of PIP 2 binding to channels retards the stimulatory effects of Gbg or Na þ ions on channel activity. Such effects can be reversed by restoring PIP 2 . Mutant channels that interact weakly with PIP 2 do not open under control conditions, but can be activated when the interaction with PIP 2 is strengthened by adding Gbg. 53 PIP 2 dramatically decreases the apparent affinity of K ATP channels (K IR 6) for ATP and thus influences responses to metabolic challenge. 54 Most K IR channels are relatively specific for PI(4,5)P 2 over other positional isomers of PIP 2 , but the K ATP channels are relatively non-specific, responding to 3,4-and 3,5-PIP 2 as well as the 4,5-isomer and even to PIP 3 . 55 The relative non-specificity of the K ATP channels means that they can be activated by lipids other than the inositol phospholipids, particularly long chain fatty acyl CoA derivatives 55, 56 and these act similarly to PIP 2 . 57 This may be of considerable functional importance as the content of these fatty acid derivatives can be manipulated by dietary lipid intake and can change under different metabolic or pathological conditions. Thus, long chain fatty acyl CoA derivatives, as well as ATP may serve as metabolic regulators of K ATP channels, and this regulation will be influenced by the availability of sarcolemmal inositol phospholipids. Long chain fatty acyl CoA derivatives are elevated in type 2 diabetes and the mechanism outlined may contribute to cardiac complications of this disease. 57 It has also been reported that K ATP channels are less selective than GIRK channels in terms of the fatty acid residues constituting the PIP 2 molecule, with GIRK channels, but not K ATP channels, showing strong preference for arachidonly, stearyl PIP 2 . 56 Again, this suggests the possibility of subtype-selective dietary influence on channel activity, as it is known that fatty acid intake can alter the lipid composition of PIP 2 . 58 
Repolarizing K 1 channels
The repolarization phase of the action potential is mediated by voltage-regulated K þ channels (Kv), in particular by Kv11.1 (human ether a go, HERG) responsible for the rapid phase of repolarization and Kv 7.1 (KCNQ1/KCNE1), which causes slow repolarization. Both Kv11.1 and Kv 7.1 are activated by PIP 2 , although its interaction is less well studied than for the K IR channels. [59] [60] [61] Mutations in either of these channels have been shown to be responsible for inherited arrhythmias, particularly long Q-T syndrome (LQT), and one mutant in the Kv 7.1 channel causes short QT. [62] [63] [64] At least in Kv 7.1, some of these mutants are in residues likely to be important for PIP 2 interactions. 63 Both Kv11.1 and Kv 7.1 channels have six trans-membrane spanning regions that form an ion pore, together with a long C-terminal tail and a relatively short cytosolic N-terminal tail ( Figure 3) . HERG channels are regulated by PKA phosphorylation of C-terminal residues and by direct cAMP binding to motifs present in the C-terminal tail. The phosphorylated protein associates with 14-3-3 proteins and this interaction is central to the heightened activity. 65 There are potential PIP 2 interaction sites on both sides of the cAMP-interaction domain, 60 and it is likely that PIP 2 can influence responses to cAMP and PKA. In the HERG channel, PIP 2 causes hyperpolarizing shifts in the voltage dependence of activation and also slows deactivation, and loss of PIP 2 can explain channel deactivation, following activation of PLC-coupled receptors. 67 The slow phase of repolarization, the I KS current, is mediated by Kv7.1 channels comprising a heterodimer of a six transmembrane spanning protein, KCNQ1, and the smaller KCNE1 molecule with one membrane spanning domain. The functional channel also requires A-kinase anchoring protein 9 (AKAP9), also known as yotiao, that modulates activation by protein kinase A. 68 PIP 2 is required for Kv7.1 activity, and the PIP 2 binding site is in the Nterminal cytosolic region of the protein. The PIP 2 -binding sequence is part of an endogenous inhibitory region on KCNQ1, and PIP 2 binding prevents this inhibition (Figure 3) . 69 Mutations in critical arginine residues involved in PIP 2 binding that cause reduced PIP 2 affinity have been shown to be a cause of inherited LQT. 62 In patch clamp studies, addition of excess PIP 2 reversed the lowered activity of the mutant channels and returned channel activity to normal, further confirming the importance of PIP 2 binding for the optimal functioning of the channel 63 and raising the possibility that changes in PIP 2 availability could initiate arrhythmia.
Pacemaker channels
PIP 2 also regulates the pacemaker (I f ) current by regulating the hyperpolarization-activated cyclic nucleotide gated channels (HCN). PIP 2 shifts the voltage dependence of the pacemaker I f channels towards depolarized potentials and thus increases the spontaneous firing rate, 49, 70 but the molecular basis for this is not yet known. These channels have been suggested to be important in the development of AF, 71 but there is currently no evidence that this involves PIP 2 . The Na þ /Ca 2þ exchanger NCX1 is a large membrane protein with nine transmembrane sequences and a long cytosolic loop between transmembrane sequences 4 and 5, which include a sequence, known as the exchanger inhibitory peptide (XIP), that serves to auto-inhibit channel activity (Figure 3) .
Arrhythmic responses possibly involving
72 NCX1 contributes to arrhythmia under a number of pathological circumstances. Reverse mode (Ca 2þ entry) NCX1 is activated following Na þ influx during ischaemia/reperfusion 73 and NCX activity is required for arrhythmias in early reperfusion. [74] [75] [76] Increased expression of NCX1 has been reported in heart failure in some studies involving clinical samples and in some experimental models.
73,77 PIP 2 activates NCX1 activity by binding the XIP sequence and preventing auto-inhibition. 72, 78 Importantly, long chain fatty acyl CoA derivatives can substitute for PIP 2 as activators of NCX1. 79 As saturated fatty acyl CoA derivatives are most effective NCX1 activators, this suggests another possible mechanism whereby diet could influence predisposition to arrhythmia. In addition to activation by PIP 2 , possible effects of localized Ca 2þ signals on sarcolemmal NCX1 are often suggested as a mechanism of Ins(1,4,5)P 3 arrhythmogenesis, as noted above.
Canonical transient receptor potential channels
TrpC channels are low conductance, relatively non-selective cation channels activated by receptors coupled to PLC. [80] [81] [82] TrpC channels are regulated by stretch, DAG, and IP 3 -R-mediated Ca 2þ store depletion. 80 TrpC3, 6, and 7 are activated directly by DAG, 83, 84 whereas TrpC4 and 5 are regulated by PLC, independently of DAG formation. 85 TrpC4 can be inhibited by PIP 2 binding 82 and this may explain the activation by PLC as this would be expected to cause PIP 2 depletion. On the other hand, TrpC7 86 and human TrpC6 channels are activated by PIP 2 , which enhance store-operated Ca 2þ entry. 87 In these cases, PLC-induced depletion of PIP 2 would oppose any stimulatory effect of Ins(1,4,5)P 3 -induced Ca 2þ store depletion. A number of interesting properties of this channel family suggest a potential role in causing electrophysiological imbalance. TrpC3 is physically associated with NCX1 in cardiac sarcolemma and Ca 2þ entry via TrpC3 may partly depend on reverse mode NCX1. 88, 89 TrpC6 is activated directly and selectively by a 1A -adrenergic receptors and these have previously been implicated in arrhythmogenesis. 90, 91 TrpC1 is a stretch-activated channel in heart, 92 and stretch is associated with arrhythmia. 93, 94 Furthermore, TrpC channels, by causing localized Ca 2þ increases in the subsarcolemmal region, might interfere with the functioning of the voltage-regulated Ca 2þ channels or NCX1, as proposed earlier for Ins(1,4,5)P 3 -induced Ca 2þ release. TrpC3 protein is expressed in the surface membrane of single pacemaker cells from mouse heart and a store-operated Ca 2þ influx in pacemaker tissue has been demonstrated. Blocking this Ca 2þ influx slowed pacemaker firing rate. 95 These studies suggest that TrpC3 could be an important pacemaker current modulated by Ins(1,4,5)P 3 or PIP 2 , and could contribute to arrhythmias. In addition, it has been reported that the closely related TrpM4 channel is a calciumactivated non-selective cation channel, which is activated by Ins(1,4,5)P 3 in mouse sino-atrial node. 96 
Ischaemia and reperfusion
A number of laboratories have reported that ischaemia and post-ischaemic reperfusion are associated with heightened Ins(1,4,5)P 3 generation compared with responses under normoxic conditions. [97] [98] [99] [100] [101] [102] Evidence for an association between this Ins(1,4,5)P 3 response and arrhythmogenesis was provided by use of inhibitors of PLC to reduce Ins(1,4,5)P 3 and arrhythmia, most importantly ventricular fibrillation (VF), in parallel. 103, 104 Such studies can be questioned because all inhibitors of PLC are notoriously non-specific and in particular the aminoglycosides bind PIP 2 and interfere with channel regulation as well as Ins(1,4,5)P 3 generation. 105 However, the PLC inhibitor U-73122 was found to inhibit Ins(1,4,5)P 3 generation only when this was caused by thrombin receptor (PAR1) activation. Importantly, only thrombin-induced VF was prevented by U-73122, providing support for PLC activity as being critical for arrhythmogenesis under these conditions. 104 The heightened Ins(1,4,5)P 3 generation during postischaemic reperfusion would be expected to be accompanied by a lowering of PIP 2 in the vicinity of the PLC. Such loss of PIP 2 could cause changes in the activity of critical ion channels and exchangers as described above. However, our studies showed that PIP 2 actually increased, rather than decreased, in early post-ischaemic reperfusion and that this increase was confined to caveolar fractions. 38 Such increases in PIP 2 , if they occur in the vicinity of repolarizing K þ channels, potentially could lead to reduced APD.
The situation in ischaemia is more complex. Enhanced PLC responses have been reported, 101 but our studies showed that ischaemia caused degradation of inositol phosphates, including Ins(1,4,5)P 3 in both intact heart and cardiomyocyte models. 106, 107 However, despite this, Ins(1,4,5)P 3 responses to agonist were enhanced, rather than diminished. Ischaemia also causes rapid loss of PIP 2 and its immediate dephosphorylation product PI(4)P. 39 It remains to be established whether changes in Ins(1,4,5)P 3 or PIP 2 contribute to arrhythmia under ischaemic conditions.
Heart failure
Heart failure is the endpoint of a number of cardiac pathologies and thus can be considered to embody a number of different diseases. The failing heart is often enlarged, dilated, and fibrosed and all of these factors will predispose to arrhythmia by increasing the likelihood of re-entry mechanisms and facilitating rotor initiation and perpetuation. However, in addition, some of the cellular changes associated with heart failure may also contribute to arrhythmogenesis. Increased expression of NCX1 is common in human heart failure, 108, 109 and in arrhythmic animal models. 77, 110 As outlined above, increased NCX1 would be expected to exacerbate any arrhythmic activity of either Ins(1,4,5)P 3 or PIP 2 , as both of these can directly or indirectly influence exchanger functioning. Increased expression of IP 3 -R has also been reported in human heart failure 111 and in a rabbit model. 112 Furthermore, the failing ventricle undergoes a loss of t tubules, becoming, in that respect, more atrial-like, opening up the possibility of a greater contribution of Ins(1,4,5)P 3 and IP 3 -R to Ca 2þ regulation, as outlined earlier. 113 Myocytes from failing hearts show AP prolongation that to some extent mimics LQT, associated with alterations in repolarizing K þ currents. 114, 115 However, there is currently no evidence that the altered channel activity involves PIP 2 .
Atrial fibrillation
AF is associated with a number of different cardiac pathologies and can be initiated and sustained by a range of different mechanisms. Relatively little is known about the mechanisms involved at the cellular level and there is currently no direct evidence for an involvement of Ins(1,4,5)P 3 or PIP 2 . Heightened IP 3 -R expression in right atrial tissue from patients with AF was reported in one study, 116 but in contrast, another study investigating patients with VHD reported reduced IP 3 -R expression in right atrial tissue. 117 Mutations in KCNQ1 can cause AF, but the mutations described to date do not involve PIP 2 binding. 63, 118 The recent development of mouse models of AF should help in defining mechanisms and identifying any involvement of Ins(1,4,5)P 3 or PIP 2 .
Potential for therapy
Ins(1,4,5)P 3 does not appear to be essential for the normal functioning of the heart and therefore targeting Ins(1,4,5)P 3 as an anti-arrhythmic strategy has theoretical advantages. In practice this may be difficult. IP 3 -R blockers are notoriously non-specific and currently known PLC inhibitors are only minimally effective, have many off target effects and are often poorly tolerated. [119] [120] [121] However, recent studies in our laboratory have shown that responses to Gq-coupled receptor agonists in cardiomyocytes involve primarily only one splice variant of one PLCb subtype (PLCb1b). 122 As PLCb1b is the nuclear PLC subtype in many other cell types, 122 this raises the possibility of inhibiting PLC in a cardiac-specific manner, by interfering with the binding of the C-terminal of PLCb1b to the sarcolemma.
The many different functions that depend on PIP 2 make this an unlikely candidate for drug development. However, a number of reports suggest ways in which the interaction between PIP 2 and ion channels might be a start point for targeted anti-arrhythmic agents. As noted earlier, acyl-CoA derivatives of long chain fatty acids can compete with PIP 2 for binding K IR channels, especially Kir 6.0, or NCX1. 55 Such association reverses any effect of PIP 2 . Therefore, while manipulation of PIP 2 , itself, would be impossible or inadvisable, it might be possible to design molecules that specifically reduce PIP 2 binding to particular channels/ exchangers. However, such approaches would require knowledge of the underlying defect. Another possible approach would be to target specific subtypes of PIP5K if the subtype responsible for generating the appropriate PIP 2 pool can be identified.
